Medindia LOGIN REGISTER
Medindia
Advertisement

Endo to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference

Friday, August 6, 2010 Drug News
Advertisement
CHADDS FORD, Pa., Aug. 6 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference on Thursday, August 12, 2010, at 8:00 a.m. EDT.  Alan Levin, executive vice president and chief financial officer of Endo, will review the company's products and development programs.
Advertisement

The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section.  

About Endo
Advertisement

Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. Endo is redefining its position in the healthcare marketplace by anticipating and embracing the evolution of health decisions based on the need for high-quality and cost-effective care. We aim to be the premier partner to healthcare professionals and payment providers, delivering an innovative suite of complementary diagnostics, drugs, devices and clinical data to meet the needs of patients in areas such as pain, urology, oncology and endocrinology. For more information about Endo Pharmaceuticals, and its wholly owned subsidiary HealthTronics, Inc., please visit www.endo.com .

SOURCE Endo Pharmaceuticals

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close